Breast Cancer Screening

Advertisement
Jordana JampelBreast Cancer News | March 25, 2025
There was a 29% increase in cancer detection with AI-supported screening.
Rob DillardBreast Cancer News | March 25, 2025
A groundbreaking study has demonstrated that artificial intelligence can enhance breast cancer detection rates by almost 20%.
Dr. Sadie Dobrozsi, EvolentGenetics & Breast Cancer | March 25, 2025
Dr. Sadie Dobrozsi discusses the importance of "pan-cancer" testing, especially as it pertains to breast cancer.
Jordana JampelBreast Cancer News | March 25, 2025
The positive predictive value for cancer was 15% higher for those enrolled.
Jordana JampelGenetics & Breast Cancer | March 25, 2025
The most frequent changes detected were additional copies of chromosome 1q and losses of chromosomes 10q, 16q, and 22.
Rob DillardBreast Cancer News | March 25, 2025
A new study finds that 3D digital breast tomosynthesis is more effective at detecting BC than traditional 2D.
Rob DillardBreast Cancer News | March 25, 2025
Women who receive false-positive mammogram results are less likely to return for a follow-up screening.
Rob DillardGenetics & Breast Cancer | March 25, 2025
Researchers have completed the most extensive mapping of healthy breast tissue cells to date.
Rob DillardGenetics & Breast Cancer | March 25, 2025
While half of all carriers of inherited cancer pathogenic variants are men, not enough men undergo genetic testing.
Rob DillardHER2 Breast Cancer | March 31, 2025
Dr. Margaret Gatti-Mays talks with The Oncology Brothers about the right treatments for endocrine-resistant breast cancer.
Rob DillardBreast Cancer News | March 25, 2025
Breast cancer survivors with metabolic syndrome have shorter disease-free survival than those without metabolic syndrome.
Rob DillardHER2 Breast Cancer | March 25, 2025
Using the HER2DX genomic tool is feasible in a real-world setting of patients with early-stage HER2-positive breast cancer.
Rob DillardBreast Cancer News | March 25, 2025
Patients with breast cancer who have high levels of glycosylated hemoglobin have an increased risk of recurrence and death.
Rob DillardBreast Cancer News | March 25, 2025
For women with BRCA1 sequence variations, MRI surveillance is linked to lower breast cancer mortality.
Rob DillardBreast Cancer News | March 25, 2025
Screening and new treatments have led to a US breast cancer mortality rate that is 58% lower than in it was in the mid-1970s.
Rob DillardBreast Cancer News | March 26, 2025
Dan Forche, CEO of PreludeDx, a leader in precision medicine for early-stage breast cancer, discusses DCISionRT.
Patrick DalyBreast Cancer News | March 25, 2025
A cohort analysis found abbreviated breast MRI was an effective for cancer screening in patients with dense breasts.
Patrick DalyHR Breast Cancer | March 25, 2025
Results from the 21-gene Breast Recurrence Score commercial assay were successful predictors for cancer-specific mortality.
Rob DillardBreast Cancer News | March 25, 2025
A new study suggests that it is important to consider other risk factors for breast cancer beyond breast density.
Kaitlyn D’OnofrioBreast Cancer News | March 26, 2025
A study examined the impact of the COVID-19 pandemic on breast cancer screenings, finding a significant drop in ...
Advertisement